Metaphase II transgenesis

Area of Science:

• Mammalian genetics
• Molecular biology
• Reproductive biology

Background:

• Over 11 methods exist for introducing heritable exogenous DNA (transgenes) into mammals since 1974.
• Existing methods have varying efficiencies and applications in mammalian genome engineering.

Purpose of the Study:

• To review existing transgene delivery methods.
• To introduce and evaluate a novel method: mII transgenesis.
• To highlight the potential of mII transgenesis for mammalian genome engineering.

Main Methods:

• Review of established mammalian transgenesis techniques.
• Demonstration of mII transgenesis via microinjection of membrane-depleted sperm heads and transgene DNA into metaphase II oocytes.

Main Results:

• mII transgenesis demonstrates efficiency comparable to traditional pronuclear microinjection.
• The method involves direct injection into metaphase II oocytes using modified sperm.
• Successfully introduces potentially heritable exogenous DNA into mammals.

Conclusions:

• mII transgenesis is a viable and efficient new method for creating transgenic mammals.
• This technique facilitates the delivery of large transgenes, crucial for generating disease models.
• Offers a promising alternative for advancing mammalian genome engineering paradigms.